tonsillopharyngitis%20-%20acute%20(pediatric)
TONSILLOPHARYNGITIS - ACUTE (PEDIATRIC)
Tonsillopharyngitis is the inflammation of the tonsils and pharynx.
Etiologies include bacterial and viral pathogens.
Sore throat is the most common presenting symptom in older children.

Tonsillopharyngitis%20-%20acute%20(pediatric) Treatment

Principles of Therapy

Symptomatic Treatment - Non Group A Beta-hemolytic Streptococcus (GABHS) infection
  • Symptomatic treatment is important in the management of children with sore throat
Symptomatic Treatment - Group A Beta-hemolytic Streptococcus (GABHS) infection
  • Important in the management of children with sore throat
  • Same as for non-GABHS infection
Antimicrobial Therapy
  • Treatment started only for documented GABHS infection
  • Due to practical constraints, antibiotics may be started empirically if:
    • GABHS is clinically suspected
    • Patient is toxic-looking
    • Follow-up is not possible
  • Empiric treatment of GABHS is discouraged due to poor diagnostic accuracy even with elaborate clinical scoring systems
  • A rapid antigen detection test (RADT) or throat swab should be taken before starting empiric antibiotics
  • If antibiotics are started empirically, and culture results are negative, the antibiotic should be discontinued
  • Appropriate antibiotics prevent acute rheumatic fever (ARF), prevent suppurative complications, decrease infectivity and shorten clinical course

Pharmacotherapy

Non-group A beta-hemolytic Streptococcus (Non-GABHS) Infectoin

Simple Analgesics / Antipyretics
  • Paracetamol is the drug of choice for analgesia in sore throat
  • Aspirin is not recommended due to the risk of Reye’s syndrome
Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  • Ibuprofen is a safe and effective alternative for analgesia and antipyrexia
  • Diclofenac may also be used for against pain caused by acute tonsillopharyngitis (ATP)
  • As NSAIDs are associated with significant risk of gastrointestinal bleeding (GI) bleeding, their routine use is not recommended
Throat Lozenges/Gargle/Spray
  • May be helpful especially in those with significant throat pain or discomfort
Group A beta-hemolytic Streptococcus (GABHS) Infection

Penicillin
  • Drug of choice
  • Proven efficacy, narrow spectrum, safety and low cost
  • Full 10-day course of treatment for oral medications
  • Intramuscular (IM) penicillin may be advisable if poor compliance is a concern
Amoxicillin
  • Better tolerated than Penicillin
  • 2nd line to Penicillin in pediatric patients due to taste preference
Macrolides
  • Eg Azithromycin, Clarithromycin, Erythromycin, Roxithromycin
  • May be used for patients with Penicillin allergy
  • Local resistance patterns should be included in the consideration for an alternative antibiotic in Penicillin-allergic patients
    • Resistance rate in Taiwan is approximately 10%
  • Azithromycin or Cephalexin may be used for Erythromycin-intolerant patients
Cephalosporins
  • Eg Cefaclor, Cefadroxil, Cefdinir, Cefixime, Cefpodoxime, Cephalexin
  • Alternative to Amoxicillin for the eradication of streptococcal infection especially in recurrent cases
  • Studies show that a 5-day treatment with a cephalosporin is superior to a 10-day course with Penicillin
Clindamycin
  • May be used for those who are both Penicillin-allergic and Erythromycin-intolerant
    • Resistance rate in Taiwan is approximately 10%
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
21 Feb 2021
The efficacy and safety of the two-bag (TB) system are comparable to those of the one-bag (OB) system in adults with diabetic ketoacidosis (DKA), results of a study have shown. Both approaches can be considered in adult DKA patients.
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
05 Feb 2021

Primary immunodeficiency disease (PIDD) and allergies are two groups of conditions related to the immune system. However, they are uniquely different in terms of symptoms and treatment.